The Patent Finder

Maxim Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Maxim Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Maxim Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,790,440Methods and compositions for promoting the maturation of monocytes
Term ended
Term ended Oct 9, 2021 · From the USPTO record
Term endedTerm ended Oct 9, 2021From the USPTO record
US 6,821,510Methods and compositions for promoting the maturation of monocytes
Term ended
Term ended Oct 9, 2021 · From the USPTO record
Term endedTerm ended Oct 9, 2021From the USPTO record
US 6,893,633Methods and compositions for promoting the maturation of monocytes
Term ended
Term ended Oct 9, 2021 · From the USPTO record
Term endedTerm ended Oct 9, 2021From the USPTO record
US 6,155,266Method for treatment of cancer and infectious disease
Term ended
Term ended Dec 21, 2019 · From the USPTO record
Term endedTerm ended Dec 21, 2019From the USPTO record
US 6,730,692Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
Term ended
Term ended Jan 8, 2019 · From the USPTO record
Term endedTerm ended Jan 8, 2019From the USPTO record
US 6,498,181Synergistic tumorcidal response induced by histamine
Term ended
Term ended Jan 6, 2019 · From the USPTO record
Term endedTerm ended Jan 6, 2019From the USPTO record
US 6,071,942Elevation of circulating blood histamine levels
Term ended
Term ended Nov 13, 2017 · From the USPTO record
Term endedTerm ended Nov 13, 2017From the USPTO record
US 6,063,373Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
Term ended
Term ended Sep 17, 2017 · From the USPTO record
Term endedTerm ended Sep 17, 2017From the USPTO record
US 6,221,893Administration of histamine for therapeutic purposes
Term ended
Term ended Dec 16, 2016 · From the USPTO record
Term endedTerm ended Dec 16, 2016From the USPTO record
US 6,071,509Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
Term ended
Term ended Jul 22, 2016 · From the USPTO record
Term endedTerm ended Jul 22, 2016From the USPTO record
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited